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Summary  
a known potent inhibitor of bone resorption but its effect on cartilage nzymatic degradation has 
studied. Salmon CT, at a concentration f 0, 0.1, 0.25, 0.5, 2.5 and 50 ng/ml, was added at 24 or 72 h 
lium of chondrocytes from human osteoarthritic hips and knees. The spontaneous cotlagenolytic 
using a radioiabeled type II collagen, was inhibited by CT in a dose-dependent manner. However, 
the total collagenolytic a tivity assayed after APMA activation. Stromelysin and plasmin activity, 
dation of casein and a synthetic substrata, were also unaffected by CT. Chondrocyte phospholipase 
~d using a labeled specific substrata, was decreased by CT. Chondrocyte pre-incubation with CT 
~ased the cell binding of labeled TNF~, but did not affect IL-I~ cell binding. Attachment of 
bronectin was markedly stimulated by CT, while attachment totype II collagen was not. Significant 
Led using at least 2 or 5 ng/ml of CT. CT appears to decrease collagenolytic activity by decreasing 
for increasing its inhibition by tissue inhibitors of metalloproteinases (TIMP). CT might act on 
ldrocyte activation via mechanisms such as phospholipase A2 activity, human necrosis factor-co r 
)r expression. 
rocytes, Phospholipase A2, Degradative enzyme, Adhesion. 
Int roduct ion 
~LAGE destruction is only one of the lesions of 
~s~eoarthritis (OA), but is regarded as the most 
:~or tant  one for the progression of the disease. 
.Biochemical alterations in the extracellular 
~at r ix ,  including proteoglycan loss and a loosen- 
~g of the collagen network, are implicated in OA 
~r t i lage  destruction, Alterations of collagen and 
,~oteoglycan i OA carti lage are likely mediated 
an increased egradation, by collagenase and 
ir~melysin, respectively [1]. The regulation of 
~ synthesis and activity of these matrix 
ietalloproteinases (MMPs) may occur at several 
evels. ........ MMPs aresecreted  extracellularly as 
~ct ive  proenzymes and activated in the matrix 
~m an enzymatic ascade. Serine proteases, like 
the plasminogen activator/plasmin system, have 
been suggested to be the main activators of MMPs 
[2]. Once activated, the MMPs are inhibited by 
tissue inhibitor of metalloproteinases (TIMP), and 
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the excessive degradation of matrix in OA is 
considered to result from an imbalance between 
the mechanisms of activation and inhibit ion of 
MMPs [3]. 
The mechanism of the dysregulation of MMPs in 
OA cartilage is still unknown and probably 
complex. Cytokines, such as interleukin-1 (IL-1) 
and tumor necrosis factor-a (TNF-u) are likely to 
be involved. Both these cytokines induce the 
synthesis of MMPs [4-6] and have been detected in 
the synovial fluid from OA patients [7]. OA 
chondrocytes were also shown to have a higher 
sensitivity to the stimulation of MMPs synthesis 
by IL-1 and TNF-~ than normal cells [8, 9]. For both 
these cytokines, the high sensitivity was attr ibuted 
to an increased level of both IL-1 and TNF-u 
receptors expressed in the OA chondrocytes. The 
cytokines also induce phospholipase A2 (PLA2) 
activity, an inflammatory enzyme increased in OA 
carti lage [10] and implicated in the regulat ion of 
collagenase activity [11]. 
Cell adhesion to extracellular matrix compo- 
nents, such as f ibronectin and collagen, is another 
possible mechanism implicated in the regulat ion of 
protease synthesis. Many of the  effects of the 
extracellular molecules on cell activity are exerted 
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via the integrins receptors which are expressed by 
chondrocytes [12, 13]. Induction of MMPs syn- 
thesis by signal transduction through chondrocyte 
integrin receptors has been reported [14]. Elevated 
levels of fibronectin, demonstrated in OA cartilage 
[15] also suggest that cell-matrix interaction could 
be of importance in the regulation of OA cartilage 
cells. 
Calcitonin (CT) is mainly known as a potent 
inhibitor of osteoclastic bone resorption, which 
implicates bone attachment of osteoclasts and 
enzymatic degradation. The degradative process 
associates synthesis of various proteases and 
MMPs, activation of inactive proenzymes and 
inhibition of active enzymes [16-22]: CT is known 
to induce osteoclast retraction [23] and to interfere 
at least with some steps of the enzymatic process 
of bone resorption [17-19]. 
There are some reported studies on the effects of 
CT on articular cartilage. In vitro, CT was found 
to stimulate proteoglycan and collagen synthesis 
in animal epiphyseal cartilage [24-27] as well as in 
rabbit and human articular cartilage [28, 29]. The 
study of CT in the treatment of experimental OA 
gave conflicting results. CT was found to prevent 
cartilage destruction in rabbits treated with 
steroids, partial menisectomy or joint immobiliz- 
ation [30], but no effect on cartilage was observed 
in another menisectomy experiment [31]. 
In the present study, cultures of human OA chon- 
drocytes were used to determine whether CT could 
inhibit collagenase and stromelysin activity. The 
effect of CT on plasmin activity, PLA2 activity, cell 
binding of IL-1 and TNF-~, and cell adhesion to 
fibronectin and collagen, as regulatory mechan- 
isms of MMPs activity was also investigated. 
Mater ia l s  and  Methods  
CHONDROCYTE CULTURE 
Hips and knees of patients with OA were 
obtained at the time of joint replacement. 
Immediately after surgery, the joints were washed 
with a sterile cold physiologic saline solution and 
kept for 12h at 4°C in a Gey saline solution 
(Gibco). The grossly fibrillated cartilage surround- 
ing the area of bone exposure was dissected and 
cut into approximately 1 mm ~ fragments in the Gey 
solution. 
Chondrocytes were released by sequential enzy- 
matic digestion with 0.2% trypsin (Gibco) for 
30 min, and then 6 h with 0.2% collagenase (Sigma, 
type IV) at 37°C in Gey solution. Cells were 
obtained after fi ltration with a Blutex 82 p and 
centrifugation at 1100g for 5min [11]. They 
were counted using a Thoma cell. The ceils were 
cultured at high density (8×106/ml) in a liquid 
Suspension of HAM F12 medium (Gibco) contain- 
ing 10% Ultroser (IBF) and antibiotics (penicillin 
and streptomycin 10 000 U/ml) in a 95% air-5% 
CO2 atmosphere at 37°C. The culture medium was 
eliminated by centrifugation (1100g for 5min) 
after 24 or 72 h. 
The cells were then seeded at high density (4 × 10 ~ 
cells/0.5 ml) and cultured as described for 24 or 72 h 
in the presence of various concentrations (0, 0.1, 
0.25, 0.5, 2, 5 and 50 ng/ml) of a synthetic salmon CT 
(CALSYN, Specia). Because gelatin was present in 
the furnished solution of the hormone, it was added 
at a similar concentration i the control medium. 
At the end of the culture period, the cells and the 
medium were separated by centrifugation (1100 g 
for 5min). For enzymatic assays, cells were 
sonically disrupted (Sonimas type 25 T probe at 125 
v) by three 15 s cycles in 50 mM Tris-HCL (pH 7.5). 
In repetitive control experiments, the cells did not 
divide and kept a rounded shape at the end of the 
culture period. 
DETERMINATION OF CASE INASE ACTIVITY 
Casein, a substrate of~stromelysin, was used for 
the determination of stromelysin activity accord- 
ing to a previously reported method [32]. The 
spontaneously active caseinase activity was deter- 
mined using an incubation mixture made of: 200 ~l 
of cell homogenate or culture medium, 30 ~1 of 
buffer (0.416M Tris HC1, pH 7.5, 1.25M NaC1, 
0.083 M CaC12, 0.166% NAN3, 0.83% Triton X-100), 
50 pl of 0.5% casein fluorescein isothiocyanate. 
Caseinolytic activity was also determined after 
activation, obtained by adding 10 ~tl of 0.17M 
amino-phenyl-mercuric a etate (APMA). After 
incubation at 35°C for 4 and 24h for the two 
sets of experiments, respectively, 280 ~1 of 5% 
trichloracetic were added. The precipitate was 
eliminated by centrifugation. A 0.50 M Tris-HC1 pH 
8.5 buffer (2 ml) was added to 250 ~1 supernatant. 
Fluorescence was determined using a fluorimeter 
at k EX = 365 nm and k Em = 525 nm and expressed 
in units of fluorescence per hour of incubation and 
milligram of protein. Protein assay was done as 
previously described [33]. 
DETERMINATION OF COLLAGENASE ACTIVITY 
Digestion of 3H-labeled type II collagen (Bio- 
ethica, Lyon), was done as previously described 
[10, 32]. To determine the spontaneous collageno- 
lytic activity, the incubation mixture consisted of: 
200 ~1 cell homogenate or culture medium, 30 pl of 
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25 M NaC1, 0.083 M 
e and 0.83% (w.v) 
yl-collagen (about 
total activity of 
were added to the 
C, for 24 h without 
the reaction was 
[agen (1.5 mg/ml), 
n. After centrifu- 
supernatant was 
de using the same 
enzyme extracts, 
ntaneous radioac- 
~ce of enzymatic 
DETERMINATION OF PLASMIN ACTIVITY 
ity was determined using a kinetic 
~uring (at 405 nm) the cleavage of a 
rote (D-Val-Leu-Lys p nitroanilide, 
photometrically [34]. The incuba- 
nsisted of: 200 ~tl cell homogenate 
Lure, 700 pl buffer (0.1 M Tris-HCL 
ween-80, 0.001% NAN3), 100 ~1 of 
Results were expressed as A d.o. 
cubation and milligram of protein. 
DETERMINATION OF PLA2 ACTIVITY 
:The assay was performed using a previously 
~r ibed  method [10], using unlabeled L-~-phos- 
~ idy l -e thano lamine  and labeled l-palmitoyl- 
~C)  i~ ' linoleyl-L-3-phosphatidyl-ethanolamine 
:~EN) as substrate. Briefly, 100 nmol of substrate 
 i 5000dpm), 3% sodium deoxycholate (50,1), 
0.25 M Tris-HC1 buffer (200 pl) pH 7.5, 0.1 M CaC12 
(50~1) and 200pl of culture medium or cell 
homogenate were incubated for 4h  at 37°C. 
!}~C]-linoleic acid was then extracted with Dole's 
~eagent (isopropanol 40p., heptan 10p., H2SO4 N 
!1~!). Radioactivity was counted with 10 ml toluene 
;b~sed scintillation fluid. PLA2 activity was 
:.~alculated by subtracting the value at 0 rain and 
::the nonenzymatic degradation of the substrate !iiii}i 
measured in blanks. Results were expressed as 
disintegrations per minute per hour of incubation 
:and per milligram of protein. 
CELL B INDING OF TNF~ AND IL I~ 
Chondrocytes were cultured with increasing 
concentrations of calcitonin for 24 or 72 h, as 
described above. Cell suspensions (200 ~1) were 
then incubated in HAM F12 with [I~hI]-ILI~ or 
TNF~ (respective specific radioactivity 51.8 and 
37 GBq/~M, NEN), at final ~oncentrations of 310 
and 250 pM for 4 h at 4°C, respectively [35]. Cells 
were then washed three times and centrifuged, and 
their radioactivity was measured using liquid 
scintillation. 
CELL ADHESION 
Chondrocytes were cultured with increasing 
concentrations of calcitonin for 72 h, as described 
above. Ninety-six-well microtitration plates were 
coated with fibronectin (20pg/ml) or type II 
collagen (100 ~g/ml) for 12 h at 4°C. Unoccupied 
binding sites were then blocked by incubating the 
plates for 2h  at 24°C with 1% bovine serum 
albumin (SIGMA, low endotoxin, globulin free). 
Cells (106/ml) were incubated in the coated wells 
for 1 h at 37°C. Unattached cells were eliminated 
by lavage. Attached cells were fixed with 1% 
glutaraldehyde (15 min, 24°C) and stained with 
0.1% violet crystal for 30min. The stained 
cells were treated with 0.2% Triton × 100 for 10 min 
and its intensity measured at 570nm with a 
spectrophotometer [36]. 
STATISTICAL ANALYSIS 
Cartilage from 48 joints (42 knees and six 
femoral heads) was used. Results obtained with 
knee or hip joints were similar. For each enzyme 
or binding assay, cells deriving from only one joint 
were used to evaluate the seven concentrations of 
CT (from 0-50ng/ml) and samples from six 
different joints were tested. The effect of CT 
concentration was assayed in triplicate. Data were 
not selected. The differences between groups of 
increasing CT concentration were studied with an 
analysis of variance. When a significant difference 
was found, Student's paired t test was used to 
compared the calcitonin groups with the control 
group. 
Resu l ts  
EFFECT OF CT ON DEGRADATIVE ENZYMES 
"~ The spontaneous collagenolytic activity of 
chondrocytes was significantly (P<0.05)  de- 
creased by CT both after 24 and 72 h of incubation 
(Table I). The minimum effective concentration 
was 2ng/ml for 24h and 5ng/ml for 72h [8.5 
(P= 0.03) and 33.4% (P=0.002) decrease, respect- 
ively]. The spontaneous collagenolytic activity of 
the medium was also inhibited by CT, the mini- 
mum effective concentration being 50 ng/ml for 
24 h (32.7% decrease, P < 0.001) and 5 ng/ml for 
72 h (16% decrease, P < 0.01). The collagenolytic 
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Table I 
Effect of various concentrations ofcalcitonin on the cell and medium collagenolytic activity (Coll) of human osteoarthritic 
chondrocytes in culture 
Calc i tonin (ng/ml) 
0 0.1 0.25 0.5 2 5 50 
Cell active Coll. 
24 h Incubat ion Mean 6495 6585 6071 6028 5001" 4321" 3728* 
SD 1125 1007 474 231 478 452 534 
72 h Incubat ion Mean 7668 7766 7828 7486 7013 6991" 3898* 
SD 447 488 391 474 650 453 501 
Medium active Coll. 
24 h Incubat ion Mean 4488 4305 4266 4425 4620 4273 3020* 
SD 751 477 417 534 ' 388 651 548 
72 h Incubat ion Mean 7870 7641 7571 7226 7120 5375* 4865* 
SD 866 594 616 422 416 503 499 
Cell tota l  Coll. 
24 h Incubat ion Mean 15583 15346 15786 14983 14625 14656 13280 
SD 2370 2248 1911 2131 1595 1587 1965 
72 h Incubat ion Mean 15770 16060 15546 15378 14852 14821 12170 
SD 2582 2268 2078 2151 1933 2037 1688 
Medium total  Coll 
24 h Incubat ion Mean 8960 8555 8655 8486 :8343 8370 8106 
SD 674 588 480 522 ~74 367 605 
72 h Incubat ion Mean 12135 13080 12346 12598 13045 11745 9065* 
SD 1153 1398 1413 1607 127~ 993 938 
Col lagenolyt ic act ivity is expressed in dis integrat ions per minute per hour of incubat ion and per mi l l igram of 
protein. Act ive Coll. is the spontaneously assayed activity. Total  Coll. is the act iv i ty assayed after APMA activat ion. 
*P < 0.05. 
ac t iv i ty  was  increased  by near ly  100% by APMA 
act ivat ion .  The  APMA-act ivated  co l lageno ly t i c  
ac t iv i ty  was  unmodi f ied  by  CT, w i th  except ion  
of  a 25.2% decrease  obta ined  at  a concent ra t ion  
of  50 ng /ml  a f te r  72 h (P  < 0.001). 
The  act iv i ty  of  both  case inase  and  p lasmin  was
detected  in both  ce l l s  and  med ium,  and  increased  
w i th  the  t ime of  cu l tu re .  However ,  ca lc i ton in  had  
no c lear  ef fect  on the  act iv i ty  of  the  enzymes  (data  
not  shown) .  
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FIG. 1. Phosphol ipase A2 (PLA2) act iv i ty of cultured chondrocytes with increasing concentrat ions of salmon CT. Cells 
were incubated with CT for 24 ([7) or 72 h (m). Enzyme act ivity is expressed as dis integrat ions per minute per hour 
of incubat ion and per mi l l igram of protein. Mean + SD. *P < 0.05. 
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F~:~ ~ B~nding of (a) interleukin-l~ and (b) tumor necrosis factor-c~ on cultured chondrocytes with increasing 
~a~ion  of CT. Cells were preincubated for 24 ([3) or 72 h (m) with CT before incubation with cytokines for 4 h 
a~ ~ C Binding is expressed as disintegrations per minute per 10 G cells. Mean + SD. *P < 0.05. 
,~e  effect of CT, incubated for 24 or 72 h, on cell 
~ 2  activity are represented in Fig. 1. Cell PLA2 
~i:~ inhibited by CT, in a concentration dependent 
m~a'nner, both after 24 and  72 h of incubation. A 
:~t~istically significant inhibition was obtained 
~g: :  a minimum of 2 ng/ml (P < 0.02) after 24 h 
~ 0.5ng/ml after 72h (P< 0.01). The most 
significant decrease was 53.9% (50 ng/ml, 72 h). 
Solhble PLA2 was also significantly (P=0.04) 
de~eased with a minimum concentration of 
2:~g/ml CT after 72 h of incubation. It remained ~ iiiiil ! 
~changed after 24 h of incubation with CT. 
EFFECT OF CT ON THE B INDING OF CYTOKINES 
The results are shown in Fig. 2. The binding of 
radiolabeled cytokines was specific because it was 
found to be suppressed by cold cytokines. Cell 
preincubation with CT inhibited the binding of 
TNF~ on chondrocytes. A significant decrease was 
obtained with a minimum of 5ng/ml for 24h 
(31.2%, P< 0.01) and 2ng/ml for 72h (26.9%, 
P = 0.004). The results contrast with the absence of 
effect of CT on the cell binding of IL-I~. In other 
experiments, no effect of CT on cytokine binding 
was found when both CT and cytokines were added 
at the same time in the culture medium. 
EFFECT OF CTON CELL  ADHESION 
The results are shown in Fig. 3. CT was found to 
enhance chondrocyte adhesion t  fibronectin. A 
concentration of 5 ng/ml, which was the signifi- 
cant minimum effective value, increased cell 
adhesion by 35.4% (P=0.008). The effect was 
selective because CT did not modify cell adhesion 
to Type II colIagen in similar conditions. In other 
experiments, addition of CT at the time of cell 
incubation did not modify cell adhesion to 
fibronectin. 
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D iscuss ion  
CT is a known potent inhibitor of osteoelastic 
bone resorption. Its mechanism of action is not 
fully understood but osteoclast retraction and 
inhibition of degradative enzymes have been 
implicated [17-19, 22]. This study shows that the 
hormone may also interfere with the enzymatic 
degradation of OA cartilage by inhibiting col- 
lagenase activity. 
The determined collagenolytic activity was 
likely attributable tocollagenase. It has previously 
been shown to be similar to that obtained with a 
pure cotlagenase [37], and in the present study, 
markedly increased after APMA activation. 
Collagenolytic activity inhibition can be caused by 
a decrease in synthesis and/or activation of 
collagenase, or by an increased inhibition of 
collagenase by TIMPs. The synthesis of collagen- 
ase was probably unaffected by CT because the 
hormone did not modify the total collagenolytic 
activity obtained by APMA activation. The direct 
effect of CT on collagenase was not evaluated, and 
an effect of APMA on the hormone could be 
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Fro. 3. Chondrocyte adhesion to (a) fibronectin and (b) 
type II collagen with increasing concentrations of 
calcitonin (CT). Cells were preincubated with CT for 
72 h before incubation in wells coated with fibronectin 
and collagen for 1 h at 37°C. Adherent cells were stained 
with crystal violet and staining intensity (D.O.) was 
measured by spectrophotometry at 570 nm. Mean + SD. 
possible. However, this result is in agreement with 
a previous study showing that procollagenase 
synthesis was unmodified by CT in culture of bone 
tissue [14]. The possibility of an inhibition of 
procollagenase activation by CT is not supported 
by the lack of effect of the hormone on plasmin 
activity. In fact, plasmin is known to be a potent 
activator of collagenase [38], and has been 
suggested to be the main activator of MMPs in OA 
cartilage [2]. Interestingly, plasmin activity was 
also reported to be unaffected by CT in bone 
culture [16]. HoweVer, CT inhibition of pro- 
collagenase activation could be mediated by other 
lysosomal proteases because some of them were 
found to be inhibited by CT in bone tissue 
experiments [!'7, 18, 20]. CT inhibition of col- 
lagenolytic activity could also be related to a~ 
increased formation of TIMP, a finding previousl~ 
reported in normal rabbit articular cartilage [39]. 
Collagenase activity is known to be stimulated 
by cytokines uch as IL-1 and TNFa. An increased 
stimulation of matrix degradation by IL-1 an~ 
TNF~ was reporte~jn OA cartilage and attributed 
to a higher level of %ceptors for both cytokines on: 
OA chondrocytes [8,~9]. Inhibition of collagenase 
activity by CT could be related to an interaction of 
the hormone with the r.eceptors of cytokines. Both 
radiolabeled IL-1 and T~F~ were found to bind to 
cultured OA chondrocytes. CT did not modify 
the binding of IL-1 but significantly reduced the 
binding of TNF~. The effect was observed after the 
preincubation of cells with CT, but was not found 
when CT and TNFu were incubated together at 
the same time. This suggests that CT might 
decrease expression of TNF~ receptors. This 
possible outcome was not investigated here. 
A significant inhibition of PLA2 activity in OA 
cartilage was demonstrated in this study, and to 
our knowledge, is the first demonstration of this 
hormonal effect. Both the cellular and the soluble 
form of PLA2 were inhibited with a low concen- 
tration of CT. PLA2 activiW was studied as a 
possible activator of collagenase activity, as
previously demonstrated in culture of OA chondro- 
cytes [11]. It is known to be up-regulated by IL-1 
and TNF~ stimulation [40], and was found to be 
increased in human OA cartilage [10]. A down- 
regulation of an increased PLA2 activity by CT 
could, therefore, be related to the observed 
decrease in collagenolytic activity, but confir- 
mation of this mechanism would need furthe~ 
investigation. CT-induced inhibition of PLA~ 
might also explain the anti-inflammatory effects of 
the hormone, which were repeatedly reported 
and explained by various mechanisms including 
prostaglandin formation [41-45]. 
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